senate Bill S6555A

Relates to the New York state biomedical and biotechnological translational research and entrepreneurship initiative

download pdf

Sponsor

Co-Sponsors

view all co-sponsors

Bill Status


  • Introduced
  • In Committee
  • On Floor Calendar
    • Passed Senate
    • Passed Assembly
  • Delivered to Governor
  • Signed/Vetoed by Governor
view actions

actions

  • 05 / Feb / 2014
    • REFERRED TO COMMERCE, ECONOMIC DEVELOPMENT AND SMALL BUSINESS
  • 07 / Feb / 2014
    • AMEND AND RECOMMIT TO COMMERCE, ECONOMIC DEVELOPMENT AND SMALL BUSINESS
  • 07 / Feb / 2014
    • PRINT NUMBER 6555A
  • 29 / Apr / 2014
    • REPORTED AND COMMITTED TO FINANCE
  • 16 / Jun / 2014
    • COMMITTEE DISCHARGED AND COMMITTED TO RULES
  • 16 / Jun / 2014
    • ORDERED TO THIRD READING CAL.1398
  • 16 / Jun / 2014
    • PASSED SENATE
  • 16 / Jun / 2014
    • DELIVERED TO ASSEMBLY
  • 16 / Jun / 2014
    • REFERRED TO ECONOMIC DEVELOPMENT

Summary

Relates to the New York state biomedical and biotechnological translational research and entrepreneurship initiative.

do you support this bill?

Bill Details

See Assembly Version of this Bill:
A9000
Versions:
S6555
S6555A
Legislative Cycle:
2013-2014
Current Committee:
Law Section:
Economic Development Law
Laws Affected:
Add Art 22 ยงยง441 - 449, Ec Dev L

Sponsor Memo

BILL NUMBER:S6555A

TITLE OF BILL: An act to amend the economic development law, in
relation to the New York state biomedical and biotechnological
translational research and entrepreneurship initiative

PURPOSE: To rapidly increase biomedical and biotechnological jobs,
companies, and enhance research by creating a lab to market program at
public and private medical schools in NYS while also ensuring NYS
medical schools can maintain and recruit top tier researchers and
scientists who are critical to this development as other States make
significant investments into recruiting of star talent.

SUMMARY OF PROVISIONS: Amends the economic development law to add a
new article 22, the New York state biomedical and biotechnological
translational research and entrepreneurship initiative. key
provisions:

* State Initiative Committee - composed of several state
commissioners, chaired by Commissioners of Economic Development and
Health, this provides oversight to the program and designation of the
centers.

* Peer review Committee - selected by the chairs of the state
Initiative Committee to do qualitative review of applications. This
committee does the first review of applications before they are
submitted to the State Initiative Committee. The State Committee
cannot approve an application that is not recommended by the Peer
Review Committee.

* Application - Only a medical school can apply for designation as a
NYS biomedical and biotechnological translational research and
entrepreneurship initiative center (Center) in response to an RFP.
Applications must show 2SCRIPT funding match and demonstrate a
majority of the following:

- Commercialization - how the school will increase commercialization
of research.

- Commitment five year plan showing use of resources and personnel.

- Resources: the school has or is developing facilities, expertise,
and collaborations.

- Collaborations: entrepreneurial relationships with incubators,
hotspots, and STARTUP-NY programs, and research collaborations.

- Additional: plans for IP, training and educational programs,
integration with research and clinical activities. Also: community
support, performance metrics, economic outcomes.

* Review and approval - two-stage review:

- Peer review committee scores qualitative factors: (a) scientific and
technical merit; (b) scientific knowledge, technical capability,
clinical practice, other components needed to implement the plan; (c)
suitability of staff and collaborators; (d) school accomplishments and


expertise; (e) plans for protection of human subjects; (f) the
scientific environment; (g) appropriateness of institutional support,
equipment, and physical resources; and (h) other information as
required. Applications may be not recommended based on low score, or
as lacking significant and substantial merit, or as presenting serious
ethical problems in the protection of human subjects from research
risks, or other serious ethical problems.

- State initiative committee (unless peer review is negative) -
recommends changes and funding levels and sources. Not more than 40%
of funds can be used for any single project in any year. The committee
is required to seek geographical balance The committee is also
required to notify the legislature of its choices.

* Operation and re-designation. Requires evaluation of centers.
Failure to timely cure a deficiency results in disqualification.
Centers re-designated every five years unless they receive negative
evaluation from the peer review committee, or fail to remedy
operational defects, or if the state initiative committee determines
that such defects involve fraud, or are of such extent that they
cannot be remedied.

* Waiver - allows waiver by State committee member with approval by
the rest of the committee and DOB, of regulatory or procedural
requirements that impede project success, if the waiver is consistent
with statutes and will not impair the general health or welfare.
Appropriate alternative standards may be set in place of any waived
requirements.

* Scientific research and discovery bank program - centers can request
funds for recruitment and retention of out of state and retention of
in-state scientists and researchers necessary to projects. Funds must
be matched 2:1, and plan must be approved by the State Committee.

* Unified contract. The commissioner of economic development executes
a unified contract with each center that includes all information and
requirements relative to the project. Limits administrative overhead
of the project to 10% and prohibits indirect charges.

EXISTING LAW: New bill.

JUSTIFICATION: New York State can significantly expand high-impact,
high-value biomedical and bioscience jobs, development, and innovation
by supporting research and entrepreneurship in the state's sixteen
public and private medical school centers. Extraordinary research is
taking place at the medical schools, but researchers need assistance
in developing entrepreneurial skills and business knowledge, along
with access to sophisticated financial and intellectual property
expertise, to commercialize and bring their inventions to market.

Additionally, NYS must be proactive and provide support to maintain
the critical research infrastructure that has been created and
developed over time. As federal research dollars, and the
opportunities they create, become increasingly scarce, states are
recognizing the value provided by especially productive researchers
and the potential innovation that can result from their work as an
important asset. A number of states such as Texas and California are


investing heavily in the active recruitment of top researchers and
scientists, often seeking to pull these individuals and their research
enterprises out of the many top-tier New York institutions. New
York's medical schools are responsible for $416.5 million in research
funding upstate, and $1.8 billion downstate, including $253 million in
National Science Foundation awards and $2 billion from the National
Institutes of Health. Additionally, New York is home to seven Clinical
and Translational Science Awards (CTSA) centers. As impressive as this
is, it also leaves the schools vulnerable to downturns and changes. As
an example, the Associated Medical Schools of New York expects federal
sequestration to result in nearly 1,000 fewer National Science
Foundation grant awards, affecting the research programs and education
of 12,000 scientists and students NIH, which has already lost
one-fifth of its purchasing power over the last decade, will be forced
to cut $1.5 billion in awards to research institutions in the first
year alone. Each award is estimated to equate to seven research
positions. The scientific research and discovery bank program will
help New York protect and grow this valuable asset so we are able to
keep cutting-edge research in New York and protect the pipeline
leading to commercialization in the biomedical and biotechnological
sectors.

A potentially fertile alternate source of revenues for the schools
that also benefits the residents of this state is more rapid licensure
of inventions and techniques developed in medical school center
research laboratories. Licensure generates revenue for the schools and
the researchers, and also creates jobs and development and potential
health care benefits for New Yorkers. Current conversion of research
into licensure dollars is low: NYU gets about 50 cents for every
research dollar, and Columbia gets about 24 cents. The University of
Rochester gets about 9 cents, and Mt. Sinai about 5 cents. Most
medical school centers have a low return on investment from research
funds. The four just mentioned are all among the top 25 schools in the
country for turning research into licensing revenue. Other states and
other schools fare much worse.

Creating an entrepreneurial culture can be done by bringing existing
NYS infrastructural and economic development program components into
collaborative partnership with the schools. This could be done using
NYS Business Incubators, Hotspots, and Startup-NY tax free zones,
along with some new program approaches. Such a program combines the
strengths of medical schools and NYS incubators with strategic State
support, to leverage other-source funds in a way that will speed
commercialization of research, incentivize public-private
partnerships, and increase the depth of the research community. The
ultimate program will be similar to the Naomi Berrie Diabetes Center
program at Columbia University Medical Center, which uses research,
clinical outreach, education, and entrepreneurship as key components.

FISCAL IMPLICATIONS: Subject to appropriation.

EFFECTIVE DATE: September 1 after it becomes law.

view bill text
                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                 6555--A

                            I N  S E N A T E

                            February 5, 2014
                               ___________

Introduced  by  Sens.  GOLDEN,  GALLIVAN,  GRIFFO,  HANNON, RANZENHOFER,
  ROBACH, TKACZYK, VALESKY -- read twice and ordered printed,  and  when
  printed  to be committed to the Committee on Commerce, Economic Devel-
  opment and Small  Business  --  committee  discharged,  bill  amended,
  ordered reprinted as amended and recommitted to said committee

AN  ACT  to  amend  the economic development law, in relation to the New
  York state biomedical and biotechnological translational research  and
  entrepreneurship initiative

  THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section 1.  Legislative  intent.  The  legislature  hereby  finds  and
declares  that  a coordinated program of research, entrepreneurship, and
public-private partnerships and collaborations centered in and with  the
state's  public  and  private medical schools can significantly increase
the speed and amount  of  commercialization  of  research  from  lab  to
market,  materially expanding economic and job opportunities for all New
Yorkers in this high growth sector and increasing the likelihood of high
impact healthcare breakthroughs, which will improve the health and well-
being of New Yorkers and potentially reduce health care costs.
  The legislature further finds that although New York state's  biomedi-
cal  and  biotechnological  research and infrastructure includes many of
the nation's top institutions, researchers and scientists, and has  many
natural  advantages  compared  to  other  states, development has lagged
behind the nation as a whole and many states in job growth and  economic
activity  for  a  decade; and further, that as other states make signif-
icant and targeted  investments  to  recruit  top  tier  scientists  and
researchers,  and develop incentives that are creating rapid growth, the
gap between New York and other states will increase, along with a poten-
tial migration of scientific and research  talent  to  other  states  in
search of opportunity and professional advancement.
  The  legislature  further finds that recent changes that have made New
York's economic development programs more sophisticated and  competitive
can  be  combined  with  other  statutory  approaches  and precedents to
support and incentivize an effective plan for development of  biomedical

 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                      [ ] is old law to be omitted.
                                                           LBD13390-05-4

S. 6555--A                          2

and biotechnological entrepreneurship by and through the medical schools
in  this  state,  and declares that the program enacted by this act will
expand economic activity and job development; maintain and attract  high
quality  scientists and researchers; increase resources available to the
schools and  researchers  from  grants,  private  investments,  patents,
royalties,  and  licensure,  and  leverage significant partnerships with
public and private entities; enhance our scientific and  research  capa-
bilities;  and  increase  the speed of commercialization of research and
the expansion of economic opportunity, which are in every sense  to  the
benefit of the people of this state.
  S  2.  The economic development law is amended by adding a new article
22 to read as follows:
                               ARTICLE 22
           THE NEW YORK STATE BIOMEDICAL AND BIOTECHNOLOGICAL
         TRANSLATIONAL RESEARCH AND ENTREPRENEURSHIP INITIATIVE
SECTION 441. SHORT TITLE.
        442. DEFINITIONS.
        443. NEW YORK STATE BIOMEDICAL AND BIOTECHNOLOGICAL TRANSLATION-
               AL RESEARCH AND ENTREPRENEURSHIP INITIATIVE COMMITTEE.
        444. APPLICATION FOR DESIGNATION AS A NEW YORK STATE  BIOMEDICAL
               AND  BIOTECHNOLOGICAL  TRANSLATIONAL  RESEARCH AND ENTRE-
               PRENEURSHIP INITIATIVE CENTER.
        445. REVIEW AND APPROVAL OF APPLICATIONS.
        446. WAIVER IN CERTAIN CASES.
        447. OPERATION AND RE-DESIGNATION OF NEW YORK  STATE  BIOMEDICAL
               AND  BIOTECHNOLOGICAL  TRANSLATIONAL  RESEARCH AND ENTRE-
               PRENEURSHIP INITIATIVE CENTERS.
        448. SCIENTIFIC RESEARCH AND DISCOVERY BANK PROGRAM.
        449. UNIFIED CONTRACT.
  S 441. SHORT TITLE. THIS ARTICLE SHALL BE KNOWN AND MAY  BE  CITED  AS
THE  "NEW  YORK  STATE  BIOMEDICAL  AND  BIOTECHNOLOGICAL  TRANSLATIONAL
RESEARCH AND ENTREPRENEURSHIP INITIATIVE".
  S 442. DEFINITIONS. AS USED IN THIS ARTICLE:
  1. "MEDICAL SCHOOL" MEANS A PUBLIC OR PRIVATE MEDICAL  SCHOOL  ACCRED-
ITED  BY THE LIAISON COMMITTEE ON MEDICAL EDUCATION OR THE COMMISSION ON
OSTEOPATHIC COLLEGE ACCREDITATION, OR SUCH MEDICAL SCHOOL AND AN  AFFIL-
IATED ENTITY, LOCATED IN THIS STATE.
  2.  "NEW  YORK  STATE  INCUBATORS"  AND  "NEW  YORK  STATE  INNOVATION
HOTSPOTS" OR "INCUBATORS" AND "HOTSPOTS" MEAN AND  REFER  TO  "NEW  YORK
STATE  INCUBATORS"  AND  "NEW YORK STATE INNOVATION HOTSPOTS" DESIGNATED
PURSUANT TO SECTION SIXTEEN-V OF THE URBAN DEVELOPMENT CORPORATION ACT.
  3. "PEER REVIEW COMMITTEE" MEANS THE PEER REVIEW COMMITTEE CREATED  BY
THE  DEPARTMENT  AND  THE DEPARTMENT OF HEALTH, CONSISTING OF SCIENTIFIC
AND RESEARCH EXPERTS IN BIOMEDICAL AND BIOTECHNOLOGICAL DEVELOPMENT, AND
COMPANY REPRESENTATIVES AT THE EXECUTIVE OFFICER LEVEL ENGAGED IN MAKING
DEVELOPMENT, FINANCING, AND COMMERCIALIZATION OF BIOMEDICAL AND BIOTECH-
NOLOGICAL RESEARCH.
  4. "PLAN" MEANS THE MULTI-YEAR PLAN THAT ACCOMPANIES  THE  APPLICATION
OF A MEDICAL SCHOOL TO BECOME A NEW YORK STATE BIOMEDICAL AND BIOTECHNO-
LOGICAL TRANSLATIONAL RESEARCH AND ENTREPRENEURSHIP INITIATIVE CENTER.
  5.  "PROJECT" IS THE EXECUTION OF AN APPROVED PLAN BY A NEW YORK STATE
BIOMEDICAL AND BIOTECHNOLOGICAL TRANSLATIONAL RESEARCH AND ENTREPRENEUR-
SHIP INITIATIVE CENTER.
  6. "START-UP NY" PROGRAM MEANS THE START-UP PROGRAM AUTHORIZED  PURSU-
ANT  TO  ARTICLE  TWENTY-ONE OF THIS CHAPTER, AND THE "TAX-FREE NY AREA"
HAS THE SAME MEANING AS IN ARTICLE TWENTY-ONE OF THIS CHAPTER.

S. 6555--A                          3

  7. "STATE INITIATIVE COMMITTEE" OR "STATE COMMITTEE" MEANS THE BIOMED-
ICAL AND BIOTECHNOLOGICAL TRANSLATIONAL  RESEARCH  AND  ENTREPRENEURSHIP
INITIATIVE COMMITTEE CREATED BY SECTION FOUR HUNDRED FORTY-THREE OF THIS
ARTICLE.
  8. "TRANSLATIONAL RESEARCH AND ENTREPRENEURSHIP CENTER" OR "CENTER" IS
THE   NEW  YORK  STATE  BIOMEDICAL  AND  BIOTECHNOLOGICAL  TRANSLATIONAL
RESEARCH AND ENTREPRENEURSHIP INITIATIVE CENTER  CREATED  AT  A  MEDICAL
SCHOOL PURSUANT TO THIS ARTICLE.
  9.  "UNIFIED  CONTRACT"  IS  THE CONTRACT BETWEEN THE DEPARTMENT AND A
MEDICAL SCHOOL THAT INCLUDES ALL ITEMS NECESSARY TO  THE  IMPLEMENTATION
AND ADMINISTRATION OF THE NEW YORK STATE BIOMEDICAL AND BIOTECHNOLOGICAL
TRANSLATIONAL   RESEARCH  AND  ENTREPRENEURSHIP  INITIATIVE  PROJECT  AS
DESCRIBED IN THIS ARTICLE BY A CENTER.
  S 443. NEW YORK STATE BIOMEDICAL  AND  BIOTECHNOLOGICAL  TRANSLATIONAL
RESEARCH  AND  ENTREPRENEURSHIP INITIATIVE COMMITTEE. THE NEW YORK STATE
BIOMEDICAL AND BIOTECHNOLOGICAL TRANSLATIONAL RESEARCH AND ENTREPRENEUR-
SHIP INITIATIVE COMMITTEE IS HEREBY CREATED, TO CONSIST OF  THE  COMMIS-
SIONERS  OF  THE DEPARTMENTS OF HEALTH, EDUCATION, ECONOMIC DEVELOPMENT,
LABOR, TAX AND FINANCE, THE CHANCELLOR OF THE STATE  UNIVERSITY  OF  NEW
YORK,  THE  CHANCELLOR OF THE CITY UNIVERSITY OF NEW YORK, THE PRESIDENT
OF THE EMPIRE STATE DEVELOPMENT CORPORATION, THE DIRECTOR OF  THE  DIVI-
SION  OF  THE  BUDGET, AND THE STATE COMPTROLLER. THE COMMITTEE SHALL BE
CHAIRED BY THE COMMISSIONER OF ECONOMIC DEVELOPMENT, AND  CO-CHAIRED  BY
THE  COMMISSIONER  OF HEALTH. COMMISSIONERS MAY BE REPRESENTED BY DESIG-
NEES AT MEETINGS OF THE COMMITTEE.
  1. POWERS AND DUTIES. THE COMMITTEE SHALL:
  (A) ESTABLISH GUIDELINES APPROPRIATE TO THE ACTIVITIES REQUIRED  UNDER
THIS ARTICLE.
  (B)  DESIGNATE AS NEW YORK STATE BIOMEDICAL AND BIOTECHNOLOGICAL TRAN-
SITIONAL  RESEARCH  AND  ENTREPRENEURSHIP  INITIATIVE  CENTERS   MEDICAL
SCHOOLS WHICH MEET THE CRITERIA ESTABLISHED IN THIS ARTICLE.
  (C)  APPROVE WAIVERS OF REGULATIONS AND PROCEDURES PURSUANT TO SECTION
FOUR HUNDRED FORTY-SEVEN OF THIS ARTICLE.
  (D) ESTABLISH A UNIFIED CONTRACT FOR PROJECTS PURSUANT TO SECTION FOUR
HUNDRED FORTY-NINE OF THIS ARTICLE.
  (E) RECEIVE AND REVIEW PERFORMANCE METRICS REPORTS FROM CENTERS.
  (F) RE-DESIGNATE THE CENTERS EVERY FIVE YEARS PURSUANT TO  THIS  ARTI-
CLE.
  (G)  DEVELOP  RESOURCES  AND PROCEDURES TO AID IN COMMERCIALIZATION OF
RESEARCH AND FUNDING OF ENTREPRENEURIAL EFFORTS CREATED AS A  RESULT  OF
PROJECTS, INCLUDING BUT NOT LIMITED TO SUCH ACTIVITIES AS PROCUREMENT OF
GOODS  OR  SERVICES  FROM  COMPANIES CREATED IN THE PROJECTS; ENDORSING,
COLLABORATING, OR UPON REQUEST OF A CENTER,  ACTING  AS  A  CO-PRINCIPAL
INVESTIGATOR OR OTHER LEVEL OF PARTICIPANT ON GRANTS OR OTHER ACTIVITIES
THAT  WILL  AID  IN FURTHERING PROJECT ACTIVITIES; AND SUCH OTHER ACTIV-
ITIES AS CAN AID RAPID COMMERCIALIZATION AS ARE PERMISSIBLE UNDER LAW.
  (H) OVERSEE AND MAKE RECOMMENDATIONS FOR APPROVAL OF  APPLICATIONS  TO
THE  SCIENTIFIC  RESEARCH AND DISCOVERY BANK CREATED BY THIS ARTICLE FOR
THE RECRUITMENT OF OUT OF STATE AND RETENTION OF  IN-STATE  STAR  SCIEN-
TISTS AND RESEARCHERS.
  (I)  UPON  REQUEST, PROVIDE TECHNICAL ASSISTANCE TO APPLICANTS, AND AS
MAY BE NEEDED FOR SUCCESSFUL IMPLEMENTATION OF A PROJECT, INCLUDING  BUT
NOT  LIMITED  TO  ASSISTANCE  IN IDENTIFYING AND OBTAINING RESOURCES AND
FUNDING.
  (J) IDENTIFY STATUTORY REQUIREMENTS THAT THE COMMITTEE VIEWS AS IMPED-
IMENTS TO SUCCESSFUL IMPLEMENTATION OF APPROVED PLANS, AND AS NECESSARY,

S. 6555--A                          4

SUBMIT REQUESTS TO THE LEGISLATURE IN ACCORDANCE WITH ARTICLE VII OF THE
STATE CONSTITUTION FOR  SPECIFIC  LEGISLATIVE  ENACTMENTS  NECESSARY  TO
REMOVE SUCH IMPEDIMENTS.
  (K) ENTER INTO AGREEMENTS BETWEEN AND AMONG THE MEMBERS OF THE COMMIT-
TEE AS NECESSARY TO DELINEATE THEIR RESPECTIVE ROLES REGARDING THE COOP-
ERATIVE PROVISION OF FUNDING AND ASSISTANCE.
  2.  THE  COMMITTEE  MAY ACT THROUGH ITS CHAIRS IN ALL MATTERS OF OVER-
SIGHT AND IMPLEMENTATION OF THE PROGRAM AUTHORIZED BY THIS ARTICLE.
  S 444. APPLICATION FOR DESIGNATION AS A NEW YORK STATE BIOMEDICAL  AND
BIOTECHNOLOGICAL  TRANSLATIONAL RESEARCH AND ENTREPRENEURSHIP INITIATIVE
CENTER. IN RESPONSE TO A REQUEST FOR PROPOSALS, A MEDICAL  SCHOOL  OR  A
MEDICAL SCHOOL AND AN AFFILIATED ENTITY MAY APPLY FOR FUNDING AND DESIG-
NATION AS A NEW YORK STATE BIOMEDICAL AND BIOTECHNOLOGICAL TRANSLATIONAL
RESEARCH  AND ENTREPRENEURSHIP INITIATIVE CENTER BY SUBMITTING AN APPLI-
CATION AND PLAN TO THE COMMISSIONER. THE COMMISSIONER SHALL FORWARD  ALL
SUCH  APPLICATIONS TO THE PEER REVIEW COMMITTEE FOR REVIEW AND RECOMMEN-
DATION AS HEREIN PROVIDED, AND THEN TO THE STATE COMMITTEE. IN  ADDITION
TO SUCH OTHER ITEMS, WARRANTIES, AND INFORMATION AS THE STATE INITIATIVE
COMMITTEE  MAY REQUIRE, PLANS MUST SHOW THAT THE ACTIVITIES TO BE UNDER-
TAKEN WILL COMMERCIALIZE RESEARCH FROM LAB TO  MARKETPLACE,  DEMONSTRATE
THAT  THE  CENTER MEETS THE MATCHING FUNDS AND ENTREPRENEUR RELATIONSHIP
REQUIREMENTS HEREUNDER, AND MEET A MAJORITY  OF  THE  REMAINDER  OF  THE
FOLLOWING ITEMS:
  1.  COMMITMENT:  A MULTI-YEAR COMMITMENT TO IMPLEMENT THE PLAN, OVER A
PERIOD OF NOT LESS THAN FIVE YEARS,  DEMONSTRATED  BY  A  COMMITMENT  OF
RESOURCES,  PERSONNEL,  AND  FUNDS THAT THE SCHOOL WILL USE, DIRECTLY OR
THROUGH PARTNERSHIPS AND COLLABORATIONS, TO PROVIDE  AND/OR  INCENTIVIZE
AN  INTEGRATED PROGRAM OF RESEARCH, EDUCATION, CLINICAL PRACTICE, ENTRE-
PRENEURSHIP, FINANCING, PARTNERSHIPS,  AND  RAPID  COMMERCIALIZATION  OF
RESEARCH.  SUCH  DEMONSTRATION MAY ALSO INCLUDE CAPITAL INVESTMENTS MADE
OR PLANNED FOR  NEW  OR  REHABILITATED  RESEARCH  OR  LABORATORY  SPACE,
CONTINUED  SUPPORT  FOR  ACTIVITIES AFTER THE CONCLUSION OF THE PROJECT,
AND OTHER ACTIVITIES DEMONSTRATING COMMITMENT.
  2. RESOURCES: A DESCRIPTION OF THE ACTIONS AND RESOURCES NECESSARY  TO
MEET  THE  PLAN  OBJECTIVES  OVER ITS DURATION; A DEMONSTRATION THAT THE
MEDICAL SCHOOL HAS OR IS DEVELOPING OPERATIONAL CLINICAL FACILITIES  AND
EXPERTISE  OR EVIDENCE OF BONA FIDE COLLABORATIONS AND PARTNERSHIPS THAT
CAN PROVIDE SUCH FACILITIES AND EXPERTISE TO SUCCESSFULLY IMPLEMENT  THE
PLAN;  A DEMONSTRATION THAT THE PROJECT WILL HAVE A PROFESSIONAL MANAGE-
MENT TEAM WITH EXPERIENCE, EXPERTISE, OR CREDENTIALS IN AREAS  INCLUDING
BUT  NOT  LIMITED TO MANAGEMENT, ENTREPRENEURSHIP, BUSINESS DEVELOPMENT,
OR OTHER EQUIVALENT AREAS. THE  DEMONSTRATION  MAY  INCLUDE  RECRUITMENT
PLANS  OR  COMMITMENTS  FOR HIGH LEVEL RESEARCH PROFESSIONALS, INCLUDING
HOW THE SCHOOL WOULD MAKE USE OF THE SCIENTIFIC RESEARCH  AND  DISCOVERY
BANK.
  3.  ENTREPRENEURIAL AND RESEARCH COLLABORATIONS: EVIDENCE OF BONA FIDE
ENTREPRENEURIAL RELATIONSHIPS WITH ONE OR MORE INCUBATORS  OR  HOTSPOTS,
AND RESEARCH COLLABORATIONS WITH OTHER ENTITIES INCLUDING BUT NOT LIMIT-
ED  TO  OTHER  RESEARCH  INSTITUTIONS, PHARMACEUTICAL AND BIOMEDICAL AND
BIOTECHNOLOGY COMPANIES.
  4. LEVERAGED AND APPLIED FUNDING:  A  DEMONSTRATION  THAT  THE  SCHOOL
ALREADY  POSSESSES  OR HAS A COMMITMENT FOR AND WILL MAINTAIN DURING THE
PLAN PERIOD THE REQUIRED FUNDING MATCH RATIO OF AT LEAST TWO DOLLARS FOR
EVERY STATE DOLLAR PROVIDED PURSUANT TO  THIS  ARTICLE  TO  AN  APPROVED
PLAN,  AND  HOW  THE  SCHOOL WILL USE OTHER RESOURCES, PARTNERSHIPS, AND
COLLABORATIONS TO AID DIRECTLY OR INDIRECTLY IN ACTIVITIES  CRITICAL  TO

S. 6555--A                          5

THE COMMERCIALIZATION OF RESEARCH. INSOFAR AS PRACTICABLE, SUCH MATCHING
FUNDS  SHOULD  NOT CONSIST OF DIRECT STATE GRANTS FROM THE DEPARTMENT OR
FROM ANOTHER STATE AGENCY OR STATE PUBLIC AUTHORITY, PROVIDED THAT NOTH-
ING  IN THIS SUBDIVISION SHALL BE DEEMED TO PROHIBIT A MEDICAL SCHOOL OF
THE STATE UNIVERSITY OF NEW YORK WHICH HAS BEEN DESIGNATED AS  A  CENTER
FROM USING A PORTION OF ITS OPERATING FUNDS AS MATCHING FUNDS.
  5. ADDITIONAL PLANS AND PROGRAMS: OTHER PLANS AND PROGRAMS INTEGRAL TO
THE  SUCCESSFUL  EXECUTION  OF THE PROJECT, INCLUDING BUT NOT LIMITED TO
PATENT  AND  INTELLECTUAL  PROPERTY  PLANS,  TRAINING  AND   EDUCATIONAL
PROGRAMS,  AND EDUCATIONAL INTEGRATION WITH RESEARCH AND CLINICAL ACTIV-
ITIES.
  6. COMMUNITY SUPPORT: A DEMONSTRATION OF COMMUNITY SUPPORT FROM  BUSI-
NESS AND GOVERNMENT LEADERS AND ORGANIZATIONS.
  7. BEST PRACTICES: A DEMONSTRATION THAT THE MEDICAL SCHOOL HAS OR WILL
ADOPT  BEST PRACTICES AND USE OF MULTI-YEAR METRICS FOR PERFORMANCE, AND
THAT IT WILL REPORT DATA AS REQUESTED OR REQUIRED TO THE DEPARTMENT  AND
THE STATE INITIATIVE COMMITTEE.
  8.  PERFORMANCE METRICS: ANTICIPATED ANNUAL AND CUMULATIVE OUTCOMES OF
THE PROJECT IN TERMS OF DIRECT, INDIRECT, AND RETAINED JOBS, INVESTMENT,
AND ECONOMIC AND OTHER ACTIVITY, STATED IN  A  SPECIFIC  AND  MEASURABLE
WAY, AND RESEARCH FINDINGS AND PROGRESS.
  9.  ADVISORY COUNCIL: AN ADVISORY COUNCIL OF FIVE MEMBERS OR MORE THAT
INCLUDES ONE OR MORE EXECUTIVE OFFICERS OF FIRMS THAT HAVE BEEN  CREATED
FROM  RESEARCH  AT  THE  SCHOOL, AND INDIVIDUALS WITH EXPERTISE IN AREAS
APPROPRIATE TO THE SPECIFIC DEVELOPMENTAL  SECTOR  OR  CONCENTRATION  OF
CLIENTS, OR TO BIOMEDICAL AND BIOTECHNOLOGICAL RESEARCH AND DEVELOPMENT,
AND TO THE MISSION AND GOAL OF THE PROJECT.
  S  445.  REVIEW  AND  APPROVAL OF APPLICATIONS. REVIEW OF APPLICATIONS
SHALL TAKE PLACE AS FOLLOWS:
  1. THE COMMISSIONER SHALL REVIEW APPLICATIONS AND PLANS  RECEIVED  FOR
COMPLETENESS,  AND  THEN  FORWARD  THEM TO THE PEER REVIEW COMMITTEE. NO
PLAN SHALL BE APPROVED  BY  THE  STATE  INITIATIVE  COMMITTEE  THAT  HAS
RECEIVED  A  DESIGNATION  OF  NOT  RECOMMENDED FOR FURTHER CONSIDERATION
(NRFC) BY THE PEER REVIEW COMMITTEE. NO PLANS SHALL BE FORWARDED BY  THE
COMMISSIONER  TO EITHER COMMITTEE THAT REQUIRE THAT FUNDS MADE AVAILABLE
PURSUANT TO THIS ARTICLE SHALL BE DIRECTLY OR  INDIRECTLY  UTILIZED  FOR
RESEARCH INVOLVING HUMAN REPRODUCTIVE CLONING.
  2.  THE  MEMBERS OF THE PEER REVIEW COMMITTEE SHALL BE SELECTED BY THE
CHAIR AND THE CO-CHAIR OF THE STATE INITIATIVE  COMMITTEE  USING  GUIDE-
LINES  APPROVED  BY  SUCH  COMMITTEE,  WHICH  SHALL INCLUDE REQUIREMENTS
CONCERNING EXPERTISE AND AVOIDANCE OF CONFLICT OF INTEREST. IF NECESSARY
AND DEEMED APPROPRIATE BY THE STATE INITIATIVE COMMITTEE, PLANS  MAY  BE
SUBMITTED  BLIND  TO  THE  PEER  REVIEW  PANEL. PEER REVIEW PANELS SHALL
INCLUDE A MINIMUM OF FIVE MEMBERS.
  3. THE PEER REVIEW COMMITTEE SHALL REVIEW AND SCORE PLANS BASED ON THE
FOLLOWING CRITERIA:
  (A) SCIENTIFIC AND TECHNICAL MERIT;
  (B) THE LEVEL OF SCIENTIFIC KNOWLEDGE,  TECHNICAL  CAPABILITY,  AND/OR
CLINICAL  PRACTICE  AND  OTHER  NECESSARY  PLAN COMPONENTS THAT WOULD BE
REQUIRED TO BE HOUSED AT THE MEDICAL SCHOOL, INCLUDING IMPROVEMENTS THAT
MAY BE ANTICIPATED BASED ON THE PLAN;
  (C) THE SUITABILITY OF PRINCIPAL  INVESTIGATIONS,  COLLABORATORS,  AND
OTHER  RESEARCHERS TO THE PROJECT, INCLUDING THE EXPERIENCE AND TRAINING
OF STAFF AND COLLABORATORS;

S. 6555--A                          6

  (D) THE ONGOING RECORD OF ACCOMPLISHMENTS AND INTEGRATED EXPERTISE  AT
THE  SCHOOL  OR  AS PROPOSED IN THE PLAN, INCLUDING LEADERSHIP APPROACH,
GOVERNANCE AND ORGANIZATIONAL STRUCTURE;
  (E) PLANS FOR PROTECTION OF HUMAN SUBJECTS;
  (F) THE SCIENTIFIC ENVIRONMENT IN WHICH THE WORK WILL BE DONE;
  (G)  APPROPRIATENESS  OF  INSTITUTIONAL  SUPPORT, EQUIPMENT, AND OTHER
PHYSICAL RESOURCES; AND
  (H) SUCH OTHER INFORMATION AS THE  STATE  INITIATIVE  COMMITTEE  SHALL
REQUIRE.
  4.  AN  APPLICATION RECEIVING A LOW SCORE BY THE PEER REVIEW COMMITTEE
BASED ON THE CRITERIA IN SUBDIVISION THREE OF  THIS  SECTION,  OR  WHICH
LACKS  SIGNIFICANT  AND SUBSTANTIAL MERIT, OR WHICH PRESENTS IN THE VIEW
OF THE PEER REVIEW COMMITTEE SERIOUS ETHICAL PROBLEMS IN THE  PROTECTION
OF  HUMAN  SUBJECTS  FROM RESEARCH RISKS, OR OTHER SERIOUS ETHICAL PROB-
LEMS, SHALL BE DESIGNATED  NOT  RECOMMENDED  FOR  FURTHER  CONSIDERATION
(NRFC).  SUCH  PLANS  SHALL  BE  RETURNED TO THE COMMISSIONER AND BY THE
COMMISSIONER TO THE STATE INITIATIVE COMMITTEE WITH WRITTEN  RECOMMENDA-
TIONS FOR CHANGE.
  5.  THE  STATE INITIATIVE COMMITTEE SHALL REVIEW AND SCORE PLANS BASED
ON THE CATEGORIES REQUIRED IN THE APPLICATION PURSUANT TO  SECTION  FOUR
HUNDRED  FORTY-FOUR OF THIS ARTICLE, AND SHALL ADDITIONALLY CONSIDER THE
FOLLOWING:
  (A) THE ANTICIPATED EFFECTIVENESS OF THE  PLAN  AS  EVIDENCED  BY  THE
EXISTENCE  OF  AVAILABLE RESOURCES DEDICATED TO THE PLAN AND THE COMMIT-
MENT OF THE MEDICAL SCHOOL;
  (B) THE ABILITY OF THE APPLICANT TO UNDERTAKE AND COMPLETE  THE  PLAN,
THE  FEASIBILITY OF MEETING THE METRICS AND GOALS PROVIDED FOR DETERMIN-
ING THE SUCCESS OF THE PLAN, THE DURABILITY AND EXTENT OF THE  RELATION-
SHIPS  WITH  INCUBATORS AND HOTSPOTS, AND WITH START-UP NY PROJECTS, AND
WITH PRIVATE AND OTHER PUBLIC COLLABORATORS;
  (C) THE ABILITY OF THE APPLICANT TO PROVIDE THE NECESSARY DATA FOR  AN
EFFECTIVE EVALUATION OF THE PROJECT;
  (D)  THE AMOUNT OF FEDERAL AND PRIVATE GRANTS, OR OTHER RESOURCES THAT
WILL BE INCENTIVIZED AND MADE AVAILABLE TO THE SCHOOL TO ASSIST IN FUND-
ING OF THE PROJECT; AND
  (E) SUCH OTHER MEASURABLE CRITERIA  AS  SHALL  BE  DETERMINED  BY  THE
COMMITTEE.
  6.  PLANS  DESIGNATED  AS  NOT  RECOMMENDED  FOR FURTHER CONSIDERATION
(NRFC) BY THE PEER REVIEW COMMITTEE OR THE  STATE  INITIATIVE  COMMITTEE
SHALL  BE  RETURNED TO THE APPLICANT WITH ANY RECOMMENDATIONS FOR AMEND-
MENT AND MAY BE RESUBMITTED IN THE FOLLOWING YEAR.
  7. THE STATE INITIATIVE COMMITTEE SHALL REVIEW  THE  APPLICATIONS  AND
PLANS SUBMITTED TO IT AND RECOMMEND CHANGES AND DETERMINE FUNDING LEVELS
AND  SOURCES  TO  BE INCLUDED IN THE UNIFIED CONTRACT, PROVIDED THAT NOT
MORE THAN FORTY PERCENT OF FUNDS, APPROPRIATED PURSUANT TO THIS  ARTICLE
SHALL BE USED FOR ANY SINGLE PROJECT IN ANY YEAR. INSOFAR AS PRACTICABLE
IN  APPROVING  APPLICATIONS,  THE  COMMITTEE  SHALL  SEEK  TO  PROVIDE A
GEOGRAPHICALLY BALANCED DISTRIBUTION AMONG THE REGIONS OF THE  STATE  IN
DESIGNATING NEW YORK STATE BIOMEDICAL AND BIOTECHNOLOGICAL TRANSLATIONAL
RESEARCH AND ENTREPRENEURSHIP INITIATIVE CENTERS.
  8. AS SOON AS PRACTICABLE AFTER APPROVING AN APPLICATION THE COMMITTEE
SHALL  NOTIFY  THE  TEMPORARY PRESIDENT OF THE SENATE AND THE SPEAKER OF
THE ASSEMBLY OF ITS  APPROVAL.  SUCH  NOTIFICATION  SHALL  IDENTIFY  THE
RECIPIENT AND STATE THE PROPOSED LOCATION, THE ESTIMATED PROJECT FUNDING
AND AWARD AND PROVIDE A BRIEF DESCRIPTION OF THE PROJECT.

S. 6555--A                          7

  S  446.  WAIVER IN CERTAIN CASES. TO PROMOTE INNOVATIVE APPROACHES AND
MAXIMIZE EFFECTIVE USE OF PUBLIC MONIES AND THE LIKELIHOOD OF SUCCESS IN
OPERATION OF APPROVED NEW YORK  STATE  BIOMEDICAL  AND  BIOTECHNOLOGICAL
TRANSLATIONAL  RESEARCH  AND  ENTREPRENEURSHIP  INITIATIVE  CENTERS, AND
NOTWITHSTANDING ANY OTHER PROVISION OF LAW, THE COMMISSIONER OR DIRECTOR
OF  ANY  STATE AGENCY THAT IS A MEMBER OF THE STATE INITIATIVE COMMITTEE
MAY WAIVE, UPON APPLICATION BY SUCH CENTER AND SUBJECT TO  THE  APPROVAL
OF THE STATE INITIATIVE COMMITTEE AND THE DIRECTOR OF THE BUDGET, ANY OF
SUCH  AGENCY'S REGULATORY OR PROCEDURAL REQUIREMENTS THAT MAY IMPEDE THE
SUCCESSFUL  IMPLEMENTATION  OF  A  PROJECT  UNDERTAKEN  BY  THE  CENTER,
PROVIDED THAT SUCH WAIVER IS CONSISTENT WITH APPLICABLE STATE AND FEDER-
AL  STATUTES  AND  WILL  NOT IMPAIR THE GENERAL HEALTH OR WELFARE OF THE
PEOPLE RECEIVING SERVICES UNDER SUCH PROJECT OR OTHERS. SUCH COMMISSION-
ER OR DIRECTOR SHALL BE AUTHORIZED, IN CONSULTATION WITH THE DIRECTOR OF
THE BUDGET, TO IMPOSE APPROPRIATE ALTERNATIVE STANDARDS IN PLACE OF  ANY
WAIVED REQUIREMENTS.
  S  447.  OPERATION AND RE-DESIGNATION OF NEW YORK STATE BIOMEDICAL AND
BIOTECHNOLOGICAL TRANSLATIONAL RESEARCH AND ENTREPRENEURSHIP  INITIATIVE
CENTERS. IN ADDITION TO ANY OTHER REQUIREMENTS OF THIS ARTICLE, A CENTER
WILL  AGREE  TO PROVIDE DATA SHOWING ITS SUCCESS IN MEETING PROJECT PLAN
GOALS, INCLUDING YEAR  BY  YEAR  COMPARISON  OF  RESEARCH  ACTIVITY  AND
COMMERCIALIZATION  THEREOF,  FIRM  FINANCING  AND EQUITY CAPITAL RAISED,
PROVIDED OR LEVERAGED  FROM  ALL  SOURCES,  PERSONNEL  EMPLOYED  ON  THE
PROJECT,  AND  JOBS  CREATED  BY AND THROUGH THE PROJECT. THE DEPARTMENT
SHALL DESIGN SIMPLIFIED FORMS TO AID IN THE  SUBMISSION  OF  SUCH  DATA,
WHICH MAY BE SUBMITTED ELECTRONICALLY.
  THE CHAIRS OF THE STATE INITIATIVE COMMITTEE SHALL EVALUATE AND REPORT
ON  THE OPERATIONS OF THE CENTER USING METHODS INCLUDING BUT NOT LIMITED
TO SITE VISITS, REPORTS PURSUANT TO  SPECIFIC  INFORMATION,  AND  REVIEW
EVALUATIONS.  IF  THE CHAIRS DETERMINE THE PROJECT IS NOT PROGRESSING AS
AGREED, THE CENTER WILL BE NOTIFIED OF DEFICIENCIES AND THE CENTER SHALL
REMEDY ANY DEFICIENCIES IN ITS OPERATIONS IN A TIMELY MANNER. SUCH EVAL-
UATIONS SHALL TAKE PLACE NO LESS THAN ONCE EVERY  THREE  YEARS  OR  MORE
OFTEN  FOR  ANY  INDIVIDUAL  CENTER AT THE DISCRETION OF THE CHAIRS, AND
SHALL RESULT IN A WRITTEN REPORT THAT INCLUDES PROGRAMMATIC  AND  FISCAL
EVALUATION OF THE PROJECT AND RECOMMENDATIONS FOR IMPROVEMENT.
  FAILURE  TO  TIMELY  CURE  A  DEFICIENCY  AFTER REVIEW SHALL RESULT IN
DISQUALIFICATION OF THE MEDICAL SCHOOL AS A CENTER.
  A CENTER SHALL BE DEEMED RE-DESIGNATED  UPON  APPLICATION  EVERY  FIVE
YEARS UNLESS IT SHALL RECEIVE A NEGATIVE EVALUATION FROM THE PEER REVIEW
GROUP  ON  ITS  APPLICATION  FOR  RE-DESIGNATION, OR IF IT SHALL FAIL TO
REMEDY IDENTIFIED DEFECTS IN ITS OPERATION MADE KNOWN TO IT PURSUANT  TO
THIS  SECTION, OR IF THE STATE INITIATIVE COMMITTEE DETERMINES THAT SUCH
DEFECTS ARE OF SUCH A NATURE, INVOLVE FRAUD, OR ARE OF SUCH EXTENT  THAT
THEY CANNOT BE REMEDIED.
  S  448. SCIENTIFIC RESEARCH AND DISCOVERY BANK PROGRAM. THE SCIENTIFIC
RESEARCH AND DISCOVERY BANK PROGRAM IS  HEREBY  CREATED,  WHOSE  PURPOSE
SHALL BE TO PROVIDE FUNDS TO CENTERS FOR RECRUITMENT OF OUT OF STATE AND
RETENTION  OF  IN-STATE  SCIENTISTS  AND  RESEARCHERS  NECESSARY  TO THE
SUCCESSFUL IMPLEMENTATION OF APPROVED PROJECTS.  MONIES  SHALL  BE  MADE
AVAILABLE  TO  CENTERS  FROM FUNDS APPROPRIATED FOR THE PURPOSES OF THIS
ARTICLE, AFTER REVIEW AND UPON APPROVAL BY THE STATE INITIATIVE  COMMIT-
TEE PURSUANT TO A PLAN SUBMITTED BY A CENTER. SUCH PLAN MAY BE SUBMITTED
AT  THE TIME OF THE APPLICATION OR AT ANY TIME DURING THE IMPLEMENTATION
OF THE MULTI-YEAR APPROVED PLAN AND MUST DEMONSTRATE TO THE SATISFACTION
OF THE COMMITTEE THAT THE CENTER HAS OR WILL HAVE DURING THE  PERIOD  OF

S. 6555--A                          8

THE  GRANT A MATCH OF TWO DOLLARS FOR EVERY STATE DOLLAR PROVIDED PURSU-
ANT TO THIS SECTION. PLANS MUST SHOW THE TIMELINE  AND  USAGE  OF  FUNDS
REQUIRED  AND  SUCH  OTHER  INFORMATION  AS THE COMMITTEE SHALL REQUIRE,
INCLUDING:  THE  NEED  FOR SUCH FUNDS AND THE MANNER IN WHICH SUCH AWARD
WOULD ENHANCE THE RESEARCH  CAPABILITIES  OF  THE  CENTER  NECESSARY  TO
SUCCESSFUL  IMPLEMENTATION  OF  THE  PROJECT  PLAN;  THE  ABILITY OF THE
RESEARCHER TO LEVERAGE AND ATTRACT FEDERAL FUNDS,  VENTURE  CAPITAL  AND
PRIVATE INDUSTRY FUNDS; AND THE WILLINGNESS OF SUCH RESEARCHER TO PURSUE
ENTREPRENEURIAL  ENTERPRISES  RESULTING IN NEW BUSINESS OR THE EXPANSION
OF EXISTING BUSINESS IN THIS STATE.  THE  COMMITTEE  SHALL  ESTABLISH  A
SCHEDULE  FOR  PAYMENT  OF  THE  AWARD.  FUNDS PROVIDED PURSUANT TO THIS
SECTION MUST BE APPLIED DIRECTLY TO NECESSARY EXPENSES  FOR  RECRUITMENT
AND  RETENTION  OF  SCIENTISTS  AND RESEARCHERS, AND MAY NOT BE USED FOR
INDIRECT OR OTHER OVERHEAD COSTS OF THE MEDICAL SCHOOL. INSOFAR AS PRAC-
TICABLE, SUCH MATCHING FUNDS SHOULD NOT CONSIST OF DIRECT  STATE  GRANTS
FROM THE DEPARTMENT OR FROM ANOTHER STATE AGENCY OR STATE PUBLIC AUTHOR-
ITY, PROVIDED THAT NOTHING IN THIS SECTION SHALL BE DEEMED TO PROHIBIT A
MEDICAL SCHOOL OF THE STATE UNIVERSITY OF NEW YORK WHICH HAS BEEN DESIG-
NATED  AS A CENTER FROM USING A PORTION OF ITS OPERATING FUNDS AS MATCH-
ING FUNDS. FUNDS USED FOR MATCH MAY  INCLUDE  REASONABLE  ADMINISTRATIVE
COSTS ASSOCIATED WITH OUT OF STATE RECRUITMENT OR IN-STATE RETENTION.
  S  449.  UNIFIED  CONTRACT.  THE  COMMISSIONER  ON BEHALF OF THE STATE
INITIATIVE COMMITTEE SHALL ENTER  INTO  A  UNIFIED  CONTRACT  WITH  EACH
CENTER. THE PROVISIONS OF SUCH CONTRACT SHALL INCLUDE, BUT NOT BE LIMIT-
ED  TO:  A  DESCRIPTION  OF  PROJECT  SERVICES AND ACTIVITIES; THE PLAN;
ALLOWABLE PROJECT COSTS; SPECIFIC SOURCES OF FUNDS THAT WILL SUPPORT THE
APPROVED COSTS, INCLUDING GOVERNMENTAL  AND  NON-GOVERNMENTAL  FUNDS  OR
REVENUES  THAT  ARE PROPOSED TO BE USED IN SUPPORT OF PROJECT COSTS; AND
THE ALLOCATION OF COSTS BY FUNDING SOURCE.  THE  FORM  OF  SUCH  UNIFIED
CONTRACT  SHALL  BE  DEVELOPED  IN CONSULTATION WITH THE DIVISION OF THE
BUDGET AND THE OFFICE OF STATE COMPTROLLER. THE COMPTROLLER  IS  AUTHOR-
IZED  PURSUANT  TO A CERTIFICATE OF ALLOCATION SUBMITTED BY THE DIVISION
OF THE BUDGET TO INTERCHANGE OR TRANSFER FROM APPROPRIATIONS MADE TO THE
AGENCIES OF THE COMMITTEE OR ANY OTHER  APPROPRIATION,  AS  APPROPRIATE,
SUCH  AMOUNTS AS MAY BE REQUIRED TO FULFILL THE OBLIGATIONS OF THE STATE
PURSUANT TO SUCH UNIFIED CONTRACTS FOR PAYMENTS OF SUCH OBLIGATIONS. THE
DIVISION OF THE BUDGET SHALL PROVIDE THE CHAIRS OF  THE  SENATE  FINANCE
COMMITTEE  AND  THE  ASSEMBLY  WAYS  AND  MEANS COMMITTEE WITH QUARTERLY
REPORTS OF ALL INTERCHANGES AND TRANSFERS WHICH OCCUR PURSUANT  TO  THIS
SUBDIVISION.
  1.  ALLOWABLE COSTS FOR A PROJECT SHALL INCLUDE, BUT NOT BE LIMITED TO
COSTS REASONABLY INCURRED FOR:
  (A) PREPARATION OF THE PLAN;
  (B) ACTIVITIES AS APPROVED IN THE PROJECT APPLICATION;
  (C) EVALUATION OF THE APPROVED PROJECT; AND
  (D) RENOVATIONS TO EXISTING STRUCTURES AS MAY BE NEEDED IN FURTHERANCE
OF THE PLAN, EXCEPT THAT IN NO CASE SHALL  THE  STATE  SUPPORT  OF  SUCH
COSTS  EXCEED  EITHER  TWENTY-FIVE  PERCENT OF THE AMOUNT TO BE PROVIDED
PURSUANT TO THE CONTRACT OR FIFTY PERCENT OF THE TOTAL RENOVATION COSTS,
WHICHEVER IS LESS.
  2. FUNDING MADE AVAILABLE PURSUANT TO THIS ARTICLE SHALL NOT  BE  USED
TO SUPPLANT OTHER FUNDS FOR OPERATIONS OR PROJECTS OF A CENTER.
  IN  ADDITION  TO  THE  FOREGOING REQUIREMENTS, A CENTER SHALL AGREE TO
DEDICATE ALL FUNDS FROM ANY SUPPORT RECEIVED PURSUANT TO  THIS  ARTICLE,
EXCEPT  FOR  FUNDS RECEIVED PURSUANT TO PARAGRAPH (D) OF SUBDIVISION ONE
OF THIS SECTION, TO OPERATIONS OF  THE  CENTER  WITHOUT  DEDUCTIONS  FOR

S. 6555--A                          9

OVERHEAD,  INDIRECT  COSTS,  OR FACILITIES AND ADMINISTRATION CHARGES OF
THE MEDICAL SCHOOL, AND TO LIMIT TO TEN PERCENT OR LESS  THE  ALLOCATION
OF  FUNDS  RECEIVED  THROUGH THIS ARTICLE TO ADMINISTRATIVE COSTS OF THE
CENTER.
  S  3.  This  act  shall  take  effect  on  the first of September next
succeeding the date on which it shall have become a law.

Comments

Open Legislation comments facilitate discussion of New York State legislation. All comments are subject to moderation. Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity or hate speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Comment moderation is generally performed Monday through Friday.

By contributing or voting you agree to the Terms of Participation and verify you are over 13.